/Abbott%20Laboratories%20vials%20and%20Logo-by%20Melniov%20Dmitriy%20via%20Shutterstock.jpg)
North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products. Valued at $232.4 billion by market cap, ABT is a global leader in the large and growing in-vitro diagnostic market, and its products include pharmaceuticals, nutritional, diagnostics, and vascular products. The medical device manufacturer is expected to announce its fiscal third-quarter earnings for 2025 before the market opens on Wednesday, Oct. 15.
Ahead of the event, analysts expect ABT to report a profit of $1.30 per share on a diluted basis, up 7.4% from $1.21 per share in the year-ago quarter. The company has beat or matched Wall Street’s EPS estimates in its last four quarterly reports.